Liquid biopsies in urological cancers: what we need to know before starting using them

Expert Rev Mol Diagn. 2020 Feb;20(2):135-139. doi: 10.1080/14737159.2019.1665508. Epub 2019 Sep 11.

Authors

Tania Franceschini¹, Francesca Giunchi¹, Rodolfo Montironi², Marina Scarpelli², Antonio Lopez-Beltran³, Liang Cheng⁴, Michelangelo Fiorentino¹

Affiliations

¹ Department of Pathology, University of Bologna, Bologna, Italy.
² Department of Pathology, University of Ancona, Ancona, Italy.
³ Department of Pathology and Surgery, University of Cordoba, Cordoba, Spain.
⁴ Department of Pathology, Indiana University, Indianapolis, IN, USA.

PMID: 31509027
DOI: 10.1080/14737159.2019.1665508

No abstract available

Keywords: Genito-urinary cancer; circulating free DNA; circulating tumor cells; exosomes; liquid biopsy.

Publication types

Editorial

MeSH terms

Biomarkers, Tumor
Circulating Tumor DNA
Clinical Decision-Making
Disease Management
Disease Susceptibility
Extracellular Vesicles / metabolism
Humans
Liquid Biopsy* / methods
Liquid Biopsy* / standards
Molecular Diagnostic Techniques
Neoplastic Cells, Circulating / metabolism
Neoplastic Cells, Circulating / pathology
Urologic Neoplasms / diagnosis*
Urologic Neoplasms / etiology
Urologic Neoplasms / metabolism

Substances

Biomarkers, Tumor
Circulating Tumor DNA